ORAL FORMULATION FOR A PD-L1 INHIBITOR

Disclosed are oral formulations for a compound which modulates PD-1/PD-L1 protein/protein interaction, or a pharmaceutically acceptable salt thereof, which do not require cold chain storage. La divulgation concerne des formulations orales pour un composé qui module l'interaction protéine/protéi...

Full description

Saved in:
Bibliographic Details
Main Authors YANG, Yonglai, XIE, Xinsheng, SHETH, Trupti
Format Patent
LanguageEnglish
French
Published 23.06.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed are oral formulations for a compound which modulates PD-1/PD-L1 protein/protein interaction, or a pharmaceutically acceptable salt thereof, which do not require cold chain storage. La divulgation concerne des formulations orales pour un composé qui module l'interaction protéine/protéine PD-1/PD-L1, ou un sel pharmaceutiquement acceptable de celui-ci, qui ne nécessitent pas de stockage dans la chaîne du froid.
Bibliography:Application Number: WO2021US63965